Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Calamos Advisors LLC

Calamos Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.0% in the 4th quarter, Holdings Channel reports. The firm owned 123,108 shares of the medical equipment provider’s stock after purchasing an additional 31,249 shares during the quarter. Calamos Advisors LLC’s holdings in Intuitive Surgical were worth $41,532,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. OFI Invest Asset Management purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $25,000. Baystate Wealth Management LLC increased its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares in the last quarter. Headinvest LLC purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $28,000. Stone House Investment Management LLC increased its holdings in Intuitive Surgical by 100.0% during the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Robert Desantis sold 20,296 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the sale, the executive vice president now owns 5,507 shares in the company, valued at $2,168,656.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Robert Desantis sold 20,296 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the sale, the executive vice president now owns 5,507 shares in the company, valued at $2,168,656.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,318 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now directly owns 189 shares in the company, valued at $69,958.35. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock worth $95,927,097 over the last 90 days. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Barclays lifted their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Piper Sandler boosted their target price on shares of Intuitive Surgical from $325.00 to $425.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. Finally, Citigroup boosted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $375.70.

Intuitive Surgical Trading Down 0.4 %

ISRG stock traded down $1.54 during trading on Thursday, hitting $372.63. The company had a trading volume of 2,272,280 shares, compared to its average volume of 1,644,402. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The firm has a market capitalization of $132.08 billion, a price-to-earnings ratio of 74.39, a P/E/G ratio of 5.88 and a beta of 1.36. The business has a 50 day moving average of $387.56 and a 200 day moving average of $342.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The business had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the previous year, the firm earned $1.00 EPS. The business’s revenue for the quarter was up 11.5% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.